Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
It is unclear whether SGLT2i show reduction in mortality in all patients with type 2 or just in patients with type 2 diabetes with increased cardiovascular risk.
Read More »Lower Death Risk with SGLT2 Inhibitors in Patients with Type 2 Diabetes
How Many Types of Diabetes Are There? Two? Five? Or Eleven?
More specific classifications for the disease could lead to more personalized treatments in the future. Is it time?
Read More »Safety and Efficacy of Metformin in Severe CKD
Study confirms recent guideline changes on metformin use in moderate-to-severe chronic kidney disease.
Read More »Study Explores Mechanisms Behind Cardiovascular Benefits of SGLT2 inhibitors
Researchers complete examination of class of type 2 medication.
Read More »Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes
Very low incidence of end stage renal disease (ESRD) was found in patients with childhood-onset diabetes type 1 in Norway.
Read More »Benefits of Obesity Management in Type 2 Diabetes
Management of obesity by dietary, pharmacologic, and surgical intervention can provide very positive results.
Read More »How is Cardiovascular Health Related to Duration of Diabetes and Prediabetes?
Study finds disease duration in middle age to be independently related to development of subclinical atherosclerosis and cardiac dysfunction later in life.
Read More »American College of Physicians Recommending Controversial Increase in A1c of 7% to 8%
Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.
Read More »Eating Disorders Negative Effect on Glycemic Control
An attempt to improve diet quality in youth with type 1 yields less than promising results.
Read More »Are We Doing a Better Job of Detecting Diabetes?
While detection of type 2 diabetes for specific subgroups in the population has slightly increased, overall detection rates remain low among US adults.
Read More »